Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Symbicort
Generic name / active ingredient
budesonide and formoterol fumarate
Dosage-form class
Dosage form and presentation as documented in the linked primary label
Route
Oral inhalation
Record reviewed
2026-08-17

Copy from the pack in hand

Source-linked reading points

  • Check SYMBICORT, budesonide/formoterol, the exact 80/4.5 or 160/4.5 wording, each actuation, stated inhalation count and target market together. These numbers are identity fields for one product, not a web answer to how many times anyone should use it today.
  • In 80/4.5 and 160/4.5, the first number is the budesonide marking within the combination. Do not compare only that number to self-change strength, combine packs or convert another inhaler by a similar-looking number.
  • This historical label distinguishes the product from immediate relief of acute bronchospasm. Sudden or worsening breathing difficulty, cough or wheeze needs timely action through local emergency and existing care guidance, not repeated self-dosing, device stacking or borrowing another person's product from a webpage.
  • Existing inhalers, other asthma or allergy medicines, beta blockers, diuretics, some antidepressants, OTC products and supplements should be reviewed with the actual device and complete medicine list by a pharmacist or clinician. Do not add, split or change a combination product yourself because it shares one ingredient.

Reviewed presentation examples — compare every field

  • Per inhalation: budesonide 80 mcg + formoterol 4.5 mcg; 120 metered inhalationsNDC 0186-0372-20
  • Per inhalation: budesonide 160 mcg + formoterol 4.5 mcg; 120 metered inhalationsNDC 0186-0370-20

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-17
Source record
2 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image